Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
Mels
G C
GC
Department of Internal Medicine, Bolognini Hospital, Italy.
Roffi
L
L
Antonelli
G
G
Bellati
G
G
Pacchetti
S
S
Di Nolfo
M A
MA
Panizzuti
F
F
Moretti
G
G
Piperno
A
A
Pozzi
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000097:blood; D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000276:immunology / Q000627:therapeutic use; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009500:Neutralization Tests; D011994:Recombinant Proteins; D012008:Recurrence; D013997:Time Factors
D000906:Antibodies; D007370:Interferon Type I; D016898:Interferon-alpha; D011994:Recombinant Proteins